Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01136785 · ClinicalTrials.gov registry record · NA

Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 Diabetes

A NA study of Type 2 Diabetes and Obstructive Sleep Apnea, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT01136785 is a NA study of Type 2 Diabetes and Obstructive Sleep Apnea that has completed, run by University of Chicago. The registered enrollment target is 22 participants, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01136785, a NA study of Type 2 Diabetes and Obstructive Sleep Apnea, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The overall goal of the proposed protocol is to rigorously test the hypothesis that CPAP treatment has beneficial effects on glycemic control in patients with both type 2 diabetes (T2DM) and obstructive sleep apnea (OSA). If our hypothesis were to be proven, this would imply that CPAP treatment of OSA in patients with T2DM is an essential component of their glycemic control. The proposed work is thus expected to provide additional preventive and therapeutic approaches in the management of millions of patients with T2DM.

Conditions Studied

Type 2 Diabetes Obstructive Sleep Apnea

Interventions

  • DEVICE active CPAP Therapy
  • DEVICE sham CPAP therapy

Study Locations (1)

Illinois

  • The University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2009-11
Est. Completion 2015-08
Phase NA

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01136785

The ClinicalTrials.gov registry entry for NCT01136785 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,103-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which active CPAP Therapy is the first listed.

NCT01136785 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT01136785 about?

NCT01136785 is a clinical study titled "Effects of Continuous Positive Airway Pressure (CPAP) Treatment on Glucose Control in Patients With Type 2 Diabetes". The overall goal of the proposed protocol is to rigorously test the hypothesis that CPAP treatment has beneficial effects on glycemic control in patients with both type 2 diabetes (T2DM) and obstructive sleep apnea (OSA). If our hypothesis were to be proven, this would imply that CPAP treatment of O...

What is the current status of trial NCT01136785?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2009-11. Estimated completion is 2015-08.

What conditions does trial NCT01136785 study?

This clinical trial studies the following conditions: Type 2 Diabetes, Obstructive Sleep Apnea.

What interventions are being tested in trial NCT01136785?

The interventions under investigation include: active CPAP Therapy (DEVICE), sham CPAP therapy (DEVICE).

Who is sponsoring clinical trial NCT01136785?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01136785 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 2 Diabetes

All registered trials for this condition

Obstructive Sleep Apnea

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.